Institut Curie at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Institut Curie takes part in 8 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8042. Its program centres on metastatic uveal melanoma and hormone receptor-positive metastatic breast cancer, including monitoring with biomarkers and circulating tumour DNA. Other sessions cover immunotherapy around surgery in non-small cell lung cancer, research in ROS1-rearranged cancer and side effects of cytokine and intratumoral immunotherapies.
| Organization | ESMO 2026 Attendance |
|---|---|
Institut Curie Paris, France | |
Private non-profit cancer centre in Paris, France, combining a research centre with hospital sites. | Booth Exhibiting at Booth 8042 Satellite Fri Oct 23 09:50–10:15 Satellite Fri Oct 23 18:15–19:45 Satellite Fri Oct 23 18:15–18:20 Welcome Melanoma & skin cancers Satellite Fri Oct 23 19:15–19:40 Interactive Case and Panel Discussion: Applying Evidence to Practice Melanoma & skin cancers Satellite Sat Oct 24 13:05–13:35 Maximizing 1L outcomes in HR+ mBC Breast cancer Talk Sat Oct 24 17:00–17:15 How to monitor biomarkers and ctDNA Breast cancerBiomarkers & precision oncology Satellite Sun Oct 25 13:20–14:05 Neoadjuvant vs Perioperative Immunotherapy: An Expert Clinical Debate Lung & thoracic cancers Satellite Sun Oct 25 14:05–14:25 Looking To the Future: How Emerging Strategies Could Address Unmet Needs in NSCLC Lung & thoracic cancers Talk Sun Oct 25 15:25–15:45 Toxicities of cytokines and intratumoral immunotherapies Nursing & supportive care Chair Sun Oct 25 18:30–20:00 Talk Sun Oct 25 19:25–19:45 Ongoing research and horizon scanning in cancer with ROS1 rearrangements Lung & thoracic cancers Talk Mon Oct 26 09:30–09:50 |
Instantly find 20 buyers from Institut Curie
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction